The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
Inquirer on MSN3d
World’s first anti-depression nasal spray receives FDA approvalThe US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
About Xlear, Inc. Xlear, Inc. specializes in xylitol-based products for oral and nasal hygiene. The company is dedicated to improving health outcomes through innovative, natural solutions.
Recombu Best Lists Health & household Health care Ltd Nasal Sprays ...
Nathan Jones, CEO of Xlear, Inc. (pronounced "Clear"), officially submitted testimony to the Senate Committee on Health, Education, Labor and Pensions in support of Robert F. Kennedy Jr.'s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback